Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department

NCT06156436 is registered in ClinicalTrials.gov with ResApp Health Limited as lead sponsor.

NCT NCT06156436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06156436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study Evaluating the Use of ResAppDx v2.0 as an Aid to Diagnose Respiratory Disease in Paediatric Patients in an Emergency Department
Lead sponsor
ResApp Health Limited
Phase
Observational
Overall status
Completed
Start date
January 1, 2024
Completion date
February 29, 2024
Enrollment
75 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children, bronchiolitis, croup, lower respiratory tract infection, pneumonia, reactive airway disease